Currently Covid is definitely the higher priority than AML or Pancreatic cancer due to the amount of people it is affecting. It is what it is. The FDA is not intentionally trying to slow up trials but they do apparently have a high standard when it comes to manufacturing.
THIS was published when the hold was removed on Marker's trial. Towards the end it touches on Novartis having issues with manufacturing and the FDA too. Obviously this is after their product was already approved but none the less it shows the the standard the FDA has when it comes to manufacturing as they set the bar higher for Novartis than what was the standard during the actual trial.
News 
Market Data 
Discover 
AI
